Abstract

Many peptides interact with biological membranes, but elucidating these interactions is challenging because cellular membranes are complex and peptides are structurally flexible. To contribute to understanding how the membrane-active peptides behave near the membranes, we investigated peptide structural changes in different lipid surroundings. We focused on two antimicrobial peptides, anoplin and W-MreB1–9, and one cell-penetrating peptide, (KFF)3K. Firstly, by using circular dichroism spectroscopy, we determined the secondary structures of these peptides when interacting with micelles, liposomes, E. coli lipopolysaccharides, and live E. coli bacteria. The peptides were disordered in the buffer, but anoplin and W-MreB1–9 displayed lipid-induced helicity. Yet, structural changes of the peptide depended on the composition and concentration of the membranes. Secondly, we quantified the destructive activity of peptides against liposomes by monitoring the release of a fluorescent dye (calcein) from the liposomes treated with peptides. We observed that only for anoplin and W-MreB1–9 calcein leakage from liposomes depended on the peptide concentration. Thirdly, bacterial growth inhibition assays showed that peptide conformational changes, evoked by the lipid environments, do not directly correlate with the antimicrobial activity of the peptides. However, understanding the relation between peptide structural properties, mechanisms of membrane disruption, and their biological activities can guide the design of membrane-active peptides.

Highlights

  • The fight against pathogens resistant to antibiotics remains one of the most challenging problems of modern medicine

  • In this work, using circular dichroism (CD) and fluorescence spectroscopy, we investigated the interactions of three peptides with different cell membrane mimics, focusing on peptide conformational changes induced by the membrane

  • The peptides were further purified by semi-preparative reverse phase high-performance liquid chromatography (RP-HPLC) and their purity >98% was verified by analytical RP-HPLC and MS (Figures S2–S4)

Read more

Summary

Introduction

The fight against pathogens resistant to antibiotics remains one of the most challenging problems of modern medicine. Interactions of most AMPs with the membrane result in membrane disintegration and damage, which inhibits cellular functions and destructs the cell. An example is the conjugate of the penetratin analog (one of the CPPs) with tobramycin, developed by Schmidt et al [5,6] This conjugate destabilizes bacterial membrane and inhibits protein synthesis showing 4 to 6 times stronger bactericidal activity against E. coli and S. aureus persister cells than tobramycin alone [5]. Another example of CPP use is a hybrid of a P14LRR peptide with the aminoglycoside antibiotic kanamycin [7]. These and other examples [2] show that synergy between a CPP and antibiotic may identify effective antibacterial lead compound

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call